Arcadia Biosciences, Inc. (RKDA) Analysts See $-2.00 EPS

March 15, 2018 - By Marie Mckinney

 Arcadia Biosciences, Inc. (RKDA) Analysts See $ 2.00 EPS

Analysts expect Arcadia Biosciences, Inc. (NASDAQ:RKDA) to report $-2.00 EPS on March, 20 after the close.They anticipate $0.60 EPS change or 23.08 % from last quarter’s $-2.6 EPS. After having $-2.20 EPS previously, Arcadia Biosciences, Inc.’s analysts see -9.09 % EPS growth. The stock increased 311.23% or $36.32 during the last trading session, reaching $47.99. About 13.86M shares traded or 3528.85% up from the average. Arcadia Biosciences, Inc. (NASDAQ:RKDA) has declined 43.32% since March 15, 2017 and is downtrending. It has underperformed by 60.02% the S&P500.

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Ratings Coverage

Among 2 analysts covering Arcadia Biosciences (NASDAQ:RKDA), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Arcadia Biosciences had 2 analyst reports since May 12, 2017 according to SRatingsIntel. Piper Jaffray maintained Arcadia Biosciences, Inc. (NASDAQ:RKDA) rating on Friday, July 21. Piper Jaffray has “Hold” rating and $100 target. The firm has “Neutral” rating by PiperJaffray given on Friday, May 12.

Arcadia Biosciences, Inc., an agricultural biotechnology trait company, develops traits that enhance food, feed, and fiber crops worldwide. The company has market cap of $102.42 million. The firm offers a suite of agricultural yield traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, herbicide tolerance, and heat tolerance traits, as well as yield and agronomic trait stacks primarily for food crops, such as corn, rice, wheat, and soybean. It currently has negative earnings. It also provides agricultural product quality traits comprising gamma linolenic acid safflower oil to manufacturers of nutritional supplements, medical foods, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products.

More notable recent Arcadia Biosciences, Inc. (NASDAQ:RKDA) news were published by: which released: “Arcadia Biosciences Inc.” on May 10, 2017, also with their article: “Arcadia Biosciences Achieves Key Resistant Starch Wheat Technology Milestones …” published on March 14, 2018, published: “Arcadia continues rally, up 65%” on March 12, 2018. More interesting news about Arcadia Biosciences, Inc. (NASDAQ:RKDA) were released by: and their article: “UPDATE: Arcadia Biosciences stock surges 311% after news company has met …” published on March 14, 2018 as well as‘s news article titled: “Mid-Afternoon Market Update: Intellia Therapeutics Slides Following Q4 Results …” with publication date: March 14, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.